Vital Farms, Inc. (VITL)

NASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-10-23

$9.14-2.87%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Vital Farms, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	228.6M
EPS	—	0.199
FY 2026 · Annual
Revenue	—	766.27M
EPS	—	-0.53
Capital expenditure	$70M–$75M	—
FY 2027 · Annual
Revenue	—	821.14M
EPS	—	0.269

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Capex reduces to about $72.5 million	A supporting condition in Vital Farms, Inc.'s published investment case. The stated target is ~$72.5 million.	Intact	capex exceeds $75 million in FY26	Capital expenditures: $16.704M FY2026-Q2; GAAP. Published target: ~$72.5 million. Target period is not explicitly aligned with this observation. Source published Aug 6, 202616,704,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 28, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Operating income improves from -$2.3 million in Q1 2026	Management aims to improve operating income from a loss.	Broken	operating income remains negative through FY26	Operating income: $-40.146M FY2026-Q2; GAAP. Published target: operating income improves to positive by FY26 end. Target period is not explicitly aligned with this observation. Source published Aug 6, 2026-40,146,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 28, 2026 Source: company_financial_results. Reference: f9e3d58a-daba-44ec-bfba-34b2317ec671. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Complete exit of butter products by end of FY26	The company is cutting unprofitable butter products to focus on eggs.	Intact	butter product exit delayed beyond FY26	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue grows to about $787.5 million	A primary condition in Vital Farms, Inc.'s published investment case. The stated target is ~$787.5 million.	Intact	revenue falls below $755 million in FY26	Revenue: $166.029M FY2026-Q2; GAAP. Published target: ~$787.5 million. Target period is not explicitly aligned with this observation. Source published Aug 6, 2026166,029,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 28, 2026 Source: company_financial_results. Reference: f9e3d58a-daba-44ec-bfba-34b2317ec671. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-28 · fmp

FY2027 EPSUnavailable

$0.22 → Unavailable · observed estimates

FY2027 revenue$0.82B

$0.83B → $0.82B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.22	$834,750,122	5 / 7
2026-07-25	$0.22	$834,750,122	5 / 7
2026-07-26	$0.22	$833,194,567	5 / 7
2026-07-27	$0.22	$833,194,567	5 / 7
2026-07-28	$0.22	$833,194,567	5 / 7
2026-07-29	$0.22	$833,194,567	5 / 7
2026-07-30	$0.22	$833,194,567	5 / 7
2026-07-31	$0.22	$833,194,567	5 / 7
2026-08-01	$0.22	$833,194,567	5 / 7
2026-08-02	$0.22	$833,194,567	5 / 7
2026-08-03	$0.22	$833,194,567	5 / 7
2026-08-04	$0.22	$831,072,344	5 / 7
2026-08-05	$0.22	$831,072,344	5 / 7
2026-08-06	$0.22	$831,072,344	5 / 7
2026-08-08	$0.23	$831,072,343	6 / 7
2026-08-09	$0.23	$831,072,343	6 / 7
2026-08-10	$0.23	$831,072,343	6 / 7
2026-08-12	$0.23	$831,072,343	6 / 7
2026-08-13	$0.23	$831,072,343	6 / 7
2026-08-14	$0.23	$831,072,343	6 / 7
2026-08-15	$0.23	$831,072,343	6 / 7
2026-08-16	$0.23	$831,072,343	5 / 7
2026-08-17	$0.23	$831,072,343	5 / 7
2026-08-18	$0.23	$831,072,343	5 / 7
2026-08-19	$0.23	$831,072,343	5 / 7
2026-08-20	$0.32	$824,789,390	5 / 7
2026-08-21	$0.32	$824,789,390	5 / 7
2026-08-22	$0.32	$824,789,390	5 / 7
2026-08-23	$0.32	$824,789,390	5 / 7
2026-08-24	$0.32	$824,789,390	5 / 7
2026-08-25	$0.32	$824,789,390	5 / 7
2026-08-26	$0.32	$824,789,390	5 / 7
2026-08-27	$0.32	$824,789,390	5 / 7
2026-08-28	$0.32	$824,789,390	5 / 7
2026-08-29	$0.32	$824,789,390	5 / 7
2026-08-30	$0.32	$824,789,390	5 / 7
2026-08-31	$0.32	$824,789,390	5 / 7
2026-09-01	$0.32	$824,789,390	5 / 7
2026-09-02	$0.32	$824,789,390	5 / 7
2026-09-03	$0.32	$824,789,390	5 / 7
2026-09-04	$0.32	$824,789,390	5 / 7
2026-09-05	$0.32	$824,789,390	5 / 7
2026-09-06	$0.32	$824,789,390	5 / 7
2026-09-07	$0.32	$824,789,390	5 / 7
2026-09-08	$0.32	$824,789,390	5 / 7
2026-09-09	$0.32	$824,789,390	5 / 7
2026-09-10	$0.32	$824,789,390	5 / 7
2026-09-11	$0.32	$824,789,390	5 / 7
2026-09-12	$0.32	$824,789,390	5 / 7
2026-09-13	$0.32	$824,789,390	5 / 7
2026-09-14	$0.32	$824,789,390	5 / 7
2026-09-15	$0.32	$824,789,390	5 / 7
2026-09-16	$0.32	$824,789,390	5 / 7
2026-09-17	$0.32	$824,789,390	5 / 7
2026-09-18	$0.32	$824,789,390	5 / 7
2026-09-19	$0.32	$824,789,390	5 / 7
2026-09-20	$0.32	$824,789,390	5 / 7
2026-09-21	$0.32	$824,789,390	5 / 7
2026-09-22	$0.32	$824,789,390	5 / 7
2026-09-23	$0.32	$824,789,390	5 / 7
2026-09-24	$0.32	$824,789,390	5 / 7
2026-09-25	$0.32	$823,589,390	5 / 7
2026-09-26	$0.32	$823,589,390	5 / 7
2026-09-27	$0.32	$823,589,390	5 / 7
2026-09-28	$0.32	$823,589,390	5 / 7
2026-09-29	$0.32	$823,589,390	5 / 7
2026-09-30	$0.32	$823,589,390	5 / 7
2026-10-01	$0.32	$823,589,390	5 / 7
2026-10-02	$0.32	$823,589,390	5 / 7
2026-10-03	$0.32	$823,589,390	5 / 7
2026-10-04	$0.32	$823,589,390	5 / 7
2026-10-05	$0.32	$823,589,390	5 / 7
2026-10-06	$0.32	$823,589,390	5 / 7
2026-10-07	$0.32	$823,589,390	5 / 7
2026-10-08	$0.32	$823,589,390	5 / 7
2026-10-09	$0.32	$823,589,390	5 / 7
2026-10-10	$0.32	$823,589,390	5 / 7
2026-10-11	$0.32	$823,589,390	5 / 7
2026-10-12	$0.32	$823,589,390	5 / 7
2026-10-13	$0.32	$823,589,390	5 / 7
2026-10-14	Unavailable	$822,956,980	4 / 7
2026-10-15	Unavailable	$821,136,980	4 / 7
2026-10-16	Unavailable	$821,136,980	4 / 7
2026-10-17	Unavailable	$821,136,980	4 / 7
2026-10-18	Unavailable	$821,136,980	4 / 7
2026-10-19	Unavailable	$821,136,980	4 / 7
2026-10-20	Unavailable	$821,136,980	4 / 7
2026-10-21	Unavailable	$821,136,980	4 / 7
2026-10-22	Unavailable	$821,136,980	4 / 7
2026-10-23	Unavailable	$821,136,980	4 / 7
2026-10-24	Unavailable	$821,136,980	4 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	9	8
2026-06-01	3	8
2026-07-01	3	7
2026-08-01	4	7
2026-09-01	4	6
2026-10-01	4	6

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 4 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 25–Oct 24 · 2 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Stifel NicolausOct 15 · prior Aug 7

$11.00 → $9.00-18.2%

$0$6.05$12.10

0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Capex reduces to about $72.5 millionCapital expenditures: $16.704M
Operating income improves from -$2.3 million in Q1 2026Published status: Broken
Complete exit of butter products by end of FY26Qualitative condition
Revenue grows to about $787.5 millionRevenue: $166.029M

Next proof point

Nov 3, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.2%Typical daily move · historical

Downside history

-78.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Vital Farms, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a challenged growth business with elevated execution risk, rather than a proven durable compounder. The thesis is in a watch state: management is working to address oversupply and costs, but recent results remain weak.

What's priced into Vital Farms, Inc.

VITL trades at a 2.68-times premium to peers, while the model’s expectations gap is near zero and its confidence is low. The evidence labels the valuation as justified, with low fragility, but that does not remove the risk that weak execution continues.

What the fundamentals likely do

Near-term fundamentals remain pressured: second-quarter net revenue fell 10.1% year over year, and gross margin declined to 6.6% amid oversupply and price pressure. Management reaffirmed fiscal 2026 revenue guidance of $775 million to $800 million after lowering it from $900 million to $920 million earlier, while also managing supply, reducing overhead, and winding down butter, which brought $7.8 million in exit costs.

What Vital Farms, Inc. hinges on

The main swing factor is whether supply control and contract changes improve margins and volume without another guidance cut. A weakening jobs trend could add pressure, while stronger results and guidance from sector peers could support sentiment toward the group.